Session Details

[29-28-am]Biomolecules 4

Sun. Mar 29, 2026 9:30 AM - 11:30 AM JST
Sun. Mar 29, 2026 12:30 AM - 2:30 AM UTC
Room 28 (3201, Bldg. 3, Area 4 [2F])
Chair: Tomoka Takatani-Nakase, Koji Matsuhisa

[29-28-am01S]Functional analysis of DNA topoisomerase Ⅱ in ES cells

○Yuki Nishinaka1, Yuriko Hishida1, Shigehiro Osada1, Tomoaki Hishida1 (1. Wakayama.Medical.University.Pharm)

[29-28-am02S]Roles of the ALDH Domain and Active Center in the Formation of High Molecular Weight Species of 10-Formyltetrahydrofolate Metabolizing Enzymes

○Rira Akutagawa1, Ryuta Iseda1, Sara Yanagisawa1, Yutaka Tanaka1, Fumie Itoh1, Sachiko Komatsu1, Kazuhiro Watanabe1, Tsutomu Fujimura1, Masato Sasaki1 (1. Tohoku medical and pharmaceutical university)

[29-28-am03S]Development of histone acetylation catalysts for distinguishing the distance of nucleosomes

○Ayaka Nakashima1, Mayo Yamazaki1, Shigehiro Kawashima1, Motomu Kanai1 (1. Grad. Sch. Pharm. Sci., The Univ. of Tokyo)

[29-28-am04S]Mechanism of thiopurine-induced adverse events depending on NUDT15 genotypes

○Kazuki Niioka1, Yoichi Tanaka2, Mitsuru Okuwaki1 (1. Grad. Sch. Pharm. Sci., Kitasato Univ., 2. Nat Inst. Health Sci)

[29-28-am05S]Functional analysis of modified nucleosides as novel immunoregulatory factors

○Takumi Yoshioka1 (1. School of Pharmaceutical Sciences, The University of Osaka.)

[29-28-am06]Analyses on gene expressions of human DNA methyl transferase-encoding genes

○Fumiaki Uchiumi1, Reina Fujimoto1, Kirara Takita, Shigeru Hanamata1 (1. Dept. Gene Regulation, Fac. Pharm. Sci., Tokyo Univ. Sci.)

[29-28-am07]Transcriptional repression of the autism spectrum disorder-related gene SETD5 by valproic acid-induced KRAB proteins

○Tadashi Nakagawa1,2, Tomoki Tsuchida1, Toru Hosoi1 (1. Sanyo-Onoda City University, 2. Grad. Sch. Med., Tohoku Univ.)

[29-28-am08]Transcriptional regulation of TREM2 by ZEB2

○Motoaki Yanaizu1, Yuji Takata1, Masahide Kato1, Haruka Fujiwara1, Yoshihiro Kino1 (1. Meiji Pharmaceutical University)

[29-28-am09S]The cystatin-like domain of B4GALNT3 is essential for GalNAc transfer activity

○Sora Kurita1, Seita Tomida1, Yasuhiko Kizuka2, Koichi Kato1,3, Hirokazu Yagi1,3 (1. Fac. Pharm. Sci., Nagoya City Univ., 2. iGCORE, Gifu Univ., 3. ExCELLS, Natl. Inst. Nat. Sci.)

[29-28-am10S]Analysis of the regulatory mechanism of NOTCH2 signaling mediated by O-glucose glycan elongation

○Fuga Suzuki1, Yuuki Kurebayashi1, Koki Kato1, Yohei Tsukamoto1, Akira Minami1,2, Tadanobu Takahashi1, Tetsuya Okajima3,4, Hideyuki Takeuchi1 (1. Sch. Pharm. Sci., Univ. of Shizuoka, 2. Fac. Pharm., Juntendo Univ, 3. Grad. Sch. Med., Nagoya Univ, 4. iGCORE, Nagoya Univ)